Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008
- 1 March 2011
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 17 (3), 432-440
- https://doi.org/10.3201/eid1703.101553
Abstract
The Peruvian National Tuberculosis Control Program issued guidelines in 2006 specifying criteria for culture and drug-susceptibility testing (DST), including district-level rapid DST. All patients referred for culture and DST in 2 districts of Lima, Peru, during January 2005–November 2008 were monitored prospectively. Of 1,846 patients, 1,241 (67.2%) had complete DST results for isoniazid and rifampin; 419 (33.8%) patients had multidrug-resistant (MDR) TB at the time of referral. Among patients with new smear-positive TB, household contact and suspected category I failure were associated with MDR TB, compared with concurrent regional surveillance data. Among previously treated patients with smear-positive TB, adult household contact, suspected category II failure, early relapse after category I, and multiple previous TB treatments were associated with MDR TB, compared with concurrent regional surveillance data. The proportion of MDR TB detected by using guidelines was higher than that detected by a concurrent national drug-resistance survey, indicating that the strategy effectively identified patients for DST.Keywords
This publication has 20 references indexed in Scilit:
- Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in CaliforniaJournal of Clinical Microbiology, 2010
- Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysisBMC Infectious Diseases, 2009
- Epidemiology and Treatment of Multidrug Resistant TuberculosisSeminars in Respiratory and Critical Care Medicine, 2008
- Cost‐Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug‐Resistant Tuberculosis in Middle‐Income CountriesClinical Infectious Diseases, 2008
- Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, PeruEmerging Infectious Diseases, 2008
- The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2008
- Type 2 diabetes and multidrug-resistant tuberculosisScandinavian Journal of Infectious Diseases, 2008
- A web-based laboratory information system to improve quality of care of tuberculosis patients in Peru: functional requirements, implementation and usage statisticsBMC Medical Informatics and Decision Making, 2007
- Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the fieldEuropean Respiratory Journal, 2005
- Rapid and Inexpensive Drug Susceptibility Testing of Mycobacterium tuberculosis with a Nitrate Reductase AssayJournal of Clinical Microbiology, 2002